Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies - PubMed (original) (raw)
Review
Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies
Gulam Mustafa Saifi et al. J Investig Med. 2003 Sep.
Erratum in
- J Investig Med. 2004 Jan;52(1):50
Abstract
During the last decade, 18 genes and 11 additional loci harboring candidate genes have been associated with Charcot-Marie-Tooth disease (CMT) and related peripheral neuropathies. Ten of these 18 genes have been identified in the last 2 years. This phenomenal pace of CMT gene discovery has fomented an unprecedented explosion of information regarding peripheral nerve biology and its pathologic manifestations in CMT. This review integrates molecular genetics with the clinical phenotypes and provides a flowchart for molecular-based diagnostics. In addition, we discuss rational approaches to molecular therapeutics, including novel biologic molecules (eg, small interfering ribonucleic acid [siRNA], antisense RNA, and ribozymes) that potentially could be used as drugs in the future. These may be applicable in attempts to normalize gene expression in cases of CMT type 1A, wherein a 1.5 Mb genomic duplication causes an increase in gene dosage that is associated with the majority of CMT cases. Aggresome formation by the PMP22 gene product, the disease-associated gene in the duplication cases, could thus be avoided. We also discuss alternative therapeutics, in light of other neurodegenerative disorders, to disrupt such aggresomes. Finally, we review rational therapeutic approaches, including the use of antioxidants such as vitamin E, coenzyme Q10, or lipoic acid to relax potential oxidative stress in peripheral nerves, for CMT management.
Similar articles
- Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ. Braathen GJ. Acta Neurol Scand Suppl. 2012;(193):iv-22. doi: 10.1111/ane.12013. Acta Neurol Scand Suppl. 2012. PMID: 23106488 - Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.
Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, Welcher AA, Snipes GJ, Shooter EM, Patel PI, Lupski JR. Roa BB, et al. N Engl J Med. 1993 Jul 8;329(2):96-101. doi: 10.1056/NEJM199307083290205. N Engl J Med. 1993. PMID: 8510709 - [Molecular genetics of inherited neuropathies].
Takashima H. Takashima H. Rinsho Shinkeigaku. 2006 Jan;46(1):1-18. Rinsho Shinkeigaku. 2006. PMID: 16541790 Review. Japanese. - Therapeutic options in Charcot-Marie-Tooth diseases.
Mathis S, Magy L, Vallat JM. Mathis S, et al. Expert Rev Neurother. 2015 Apr;15(4):355-66. doi: 10.1586/14737175.2015.1017471. Epub 2015 Feb 21. Expert Rev Neurother. 2015. PMID: 25703094 Review. - Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K, Benes V, Thiel C, Kraus C, Kress W, Hoeltzenbein M, Ploner CJ, Kotzian J, Reis A, Rott HD, Rautenstrauss BW. Huehne K, et al. Hum Mutat. 2003 Jan;21(1):100. doi: 10.1002/humu.9101. Hum Mutat. 2003. PMID: 12497641
Cited by
- Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain.
Viana MDM, Lauria PSS, Lima AA, Opretzka LCF, Marcelino HR, Villarreal CF. Viana MDM, et al. Antioxidants (Basel). 2022 Dec 8;11(12):2420. doi: 10.3390/antiox11122420. Antioxidants (Basel). 2022. PMID: 36552628 Free PMC article. Review. - Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants.
Ferese R, Campopiano R, Scala S, D'Alessio C, Storto M, Buttari F, Centonze D, Logroscino G, Zecca C, Zampatti S, Fornai F, Cianci V, Manfroi E, Giardina E, Magnani M, Suppa A, Novelli G, Gambardella S. Ferese R, et al. Front Genet. 2021 Jul 19;12:682050. doi: 10.3389/fgene.2021.682050. eCollection 2021. Front Genet. 2021. PMID: 34354735 Free PMC article. - Epigenetic Regulation of ALS and CMT: A Lesson from Drosophila Models.
Yamaguchi M, Omori K, Asada S, Yoshida H. Yamaguchi M, et al. Int J Mol Sci. 2021 Jan 6;22(2):491. doi: 10.3390/ijms22020491. Int J Mol Sci. 2021. PMID: 33419039 Free PMC article. Review. - Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease.
Kitani-Morii F, Noto YI. Kitani-Morii F, et al. Int J Mol Sci. 2020 Oct 8;21(19):7419. doi: 10.3390/ijms21197419. Int J Mol Sci. 2020. PMID: 33049996 Free PMC article. Review. - Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway.
Leng J, Li X, Tian H, Liu C, Guo Y, Zhang S, Chu Y, Li J, Wang Y, Zhang L. Leng J, et al. BMC Complement Med Ther. 2020 Apr 26;20(1):126. doi: 10.1186/s12906-020-02930-7. BMC Complement Med Ther. 2020. PMID: 32336289 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous